Professor Ros Eeles: key facts
- Kind of voice
- Academic
- Role
- Professor of Oncogenetics at The Institute of Cancer Research, London
- Quoted on
- Cancer
- Tracked press citations
- 3
- Most recently quoted
- 30 Sept 2026
“Certain genetic changes can significantly increase a person's risk of developing cancer, such as mutations in the BRCA genes – one of which was discovered here at the ICR. With this knowledge, we can take proactive steps to reduce that risk, such as preventative surgeries and regular screening to detect cancer early. Our study adds a new layer to this understanding by exploring how psychological stress interacts with these genetic mutations.”
What Professor Ros Eeles has said
“Led the BARCODE 1 study, which explored a simple saliva test to assess genetic risk of prostate cancer – showing that, for some men, it could outperform the current PSA blood test.”
Researcher at ICR · Cancer · 30 Sept 2026 · Delivering the National Cancer Plan will depend on research – and research depends on universities ↗
“We're very pleased to see that the National Screening Committee has recommended that PSA testing for men who carry BRCA1 and BRCA2 mutations is introduced. This recommendation is based on research led by my team at The Institute of Cancer Research, which showed that these men face a significantly higher risk of developing prostate cancer and are more likely to experience aggressive forms of the disease.”
professor of oncogenetics at The Institute of Cancer Research, London · Cancer · 10 Sept 2026 · NSC to advise against whole-population NHS prostate cancer screening ↗
Where Professor Ros Eeles has been quoted
- Stress may increase cancer risk in people with inherited cancer genesicr.ac.uk · 30 Sept 2026
- Delivering the National Cancer Plan will depend on research – and research depends on universitiesicr.ac.uk · 30 Sept 2026
- NSC to advise against whole-population NHS prostate cancer screeningpulsetoday.co.uk · 10 Sept 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
- Can AI really predict cancer survival better than a doctor? I have my doubts | Devi SridharThe Guardian
- Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) CongressPR Newswire
- AJMC | Lymphoma outcomes hinge on oncology, not viral load in people with HIVEuropean AIDS Treatment Group
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.